ndividuals with symptoms suggestive of systemic lupus erythematosus (SLE), such as joint pain, skin rashes, or unexplained fever. Patients with a positive ANA test who need confirmation and assessment of lupus activity. Known SLE patients for monitoring disease severity and response to treatment.